The casino operator is running out of options as it fights to stay afloat.
The listed pharmaceuticals company was impacted by one-off hits including major customers destocking.
Market conditions are expected to remain challenging in the second half.
Company chair says share price is not where the company wants it to be.
The NZX-listed healthcare trust is again proposing to separate its New Zealand and Australian assets into distinct legal entities.
Hawke’s Bay port, the fourth-largest terminal on container traffic, recorded a 15.9% improvement in revenues.
Fast track approval not an immediate focus for Sanford managing director David Mair.
Sanford’s new managing director hints at fat-cutting plans.
The company’s trading update says margin pressure has intensified.
Pre-feasibility study for Central Otago project indicates production could start in 2026.